elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30248661-D2C13AF0-45B9-4255-B43D-DCC4FBBD2B83
Q30248661-D2C13AF0-45B9-4255-B43D-DCC4FBBD2B83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30248661-D2C13AF0-45B9-4255-B43D-DCC4FBBD2B83
Recent advances in the pathogenesis and treatment of osteoporosis
P2860
Q30248661-D2C13AF0-45B9-4255-B43D-DCC4FBBD2B83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30248661-D2C13AF0-45B9-4255-B43D-DCC4FBBD2B83
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d8592ba042b3f18856485a5109df0777430641dd
P2860
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density